Fuchu He, PhD
Professor, Beijing Institute of Lifeomics
Director, State Key Laboratory of Proteomics, China
President, National Center for Protein Sciences, Beijing
President, Beijing Proteome Research Center
Member of CAS and TWAS
Dr. He is the leading scientist studying proteomics in China and one of the pioneers pushing the Human Proteome Project in the world. He was the founder of Chinese Human Proteome Organization (CNHUPO) and among the first group of people who founded Human Proteome Organization (HUPO) in 2001. He was the first Chinese scientist who led an international consortium-Human Liver Proteome Project (HLPP), and the founder of Beijing Proteome Research Center, Phoenix Center (proteomics) and Institutes of Biomedical Sciences Fudan University. As the chief scientist, he has been propelling HLPP to the China Human Proteome Project (CNHPP), to create an encyclopedia of proteins in the human body under physiological and pathological conditions. Recently, his team stratified early hepatocarcinoma (HCC) into 3 proteomic subtypes with different clinical outcome. Some drug targetable proteins have been demonstrated useful in identifying patients with HCC who could potentially benefit from targeted treatment in further clinical trials. These studies demonstrated the proteomic analysis as an independent powerful tool in cancer molecular subtyping, indicating that the era of “Proteome Driven Precision Medicine (PDPM)” is coming.